Delaware Street Capital Master Fund, L.P., 10% Owner at KEMPHARM, INC (KMPH), bought 2,000,000 shares at $3.00 ($6.0M) on 2018-10-05, disclosed to the SEC on 2018-10-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.